132 related articles for article (PubMed ID: 34773768)
21. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03).
Wong ML; McMurry TL; Schumacher JR; Hu CY; Stukenborg GJ; Francescatti AB; Greenberg CC; Chang GJ; McKellar DP; Walter LC; Kozower BD
J Oncol Pract; 2018 Oct; 14(10):e631-e643. PubMed ID: 30207852
[TBL] [Abstract][Full Text] [Related]
22. Cancer in Canada: Stage at diagnosis.
Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of comorbidity in the lung cancer screening population: A systematic review and meta-analysis.
Almatrafi A; Thomas O; Callister M; Gabe R; Beeken RJ; Neal R
J Med Screen; 2023 Mar; 30(1):3-13. PubMed ID: 35942779
[TBL] [Abstract][Full Text] [Related]
24. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
[TBL] [Abstract][Full Text] [Related]
25. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
[TBL] [Abstract][Full Text] [Related]
26. Posttraumatic Stress Disorder and Cancer Risk: A Nested Case-Control Study.
Cohn E; Lurie I; Yang YX; Bilker WB; Haynes K; Mamtani R; Shacham-Shmueli E; Margalit O; Boursi B
J Trauma Stress; 2018 Dec; 31(6):919-926. PubMed ID: 30520529
[TBL] [Abstract][Full Text] [Related]
27. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
28. Influence of chronic comorbidities on periodic colorectal cancer screening participation: A population-based cohort study.
Bhatia D; Sutradhar R; Tinmouth J; Singh S; Lau C; Lipscombe LL
Prev Med; 2021 Jun; 147():106530. PubMed ID: 33771564
[TBL] [Abstract][Full Text] [Related]
29. Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.
Gào X; Wilsgaard T; Jansen EH; Holleczek B; Zhang Y; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2019 Jul; 145(1):49-57. PubMed ID: 30561010
[TBL] [Abstract][Full Text] [Related]
30. Serum total thiol levels and the risk of lung, colorectal, breast and prostate cancer: A prospective case-cohort study.
Gào X; Wilsgaard T; Jansen EHJM; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2020 Mar; 146(5):1261-1267. PubMed ID: 31125113
[TBL] [Abstract][Full Text] [Related]
31. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
[TBL] [Abstract][Full Text] [Related]
32. Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.
Coghill AE; Engels EA; Schymura MJ; Mahale P; Shiels MS
J Natl Cancer Inst; 2018 Sep; 110(9):959-966. PubMed ID: 29529223
[TBL] [Abstract][Full Text] [Related]
33. Association Between Alzheimer Disease and Cancer With Evaluation of Study Biases: A Systematic Review and Meta-analysis.
Ospina-Romero M; Glymour MM; Hayes-Larson E; Mayeda ER; Graff RE; Brenowitz WD; Ackley SF; Witte JS; Kobayashi LC
JAMA Netw Open; 2020 Nov; 3(11):e2025515. PubMed ID: 33185677
[TBL] [Abstract][Full Text] [Related]
34. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
[TBL] [Abstract][Full Text] [Related]
35. Calcium: magnesium intake ratio and colorectal carcinogenesis, results from the prostate, lung, colorectal, and ovarian cancer screening trial.
Zhao J; Giri A; Zhu X; Shrubsole MJ; Jiang Y; Guo X; Ness R; Seidner DL; Giovannucci E; Edwards TL; Dai Q
Br J Cancer; 2019 Oct; 121(9):796-804. PubMed ID: 31543516
[TBL] [Abstract][Full Text] [Related]
36. Personalized Risks of Over Diagnosis for Screen Detected Prostate Cancer Incorporating Patient Comorbidities: Estimation and Communication.
Gulati R; Psutka SP; Etzioni R
J Urol; 2019 Nov; 202(5):936-943. PubMed ID: 31112106
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies.
Morris JK; George LM; Wu T; Wald NJ
Br J Cancer; 2006 Jul; 95(1):112-7. PubMed ID: 16804529
[TBL] [Abstract][Full Text] [Related]
39. Evaluating factors associated with unknown SEER Summary Stage 2000 derived from collaborative stage at central registry level.
Hsieh MC; Yu Q; Wu XC; Wohler B; Fan Y; Qiao B; Jemal A; Ajani UA
J Registry Manag; 2012; 39(3):101-6. PubMed ID: 23443453
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
